Cite

HARVARD Citation

    den Uil, S. et al. (2021). Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. European journal of cancer. pp. 91-100. [Online]. 
  
Back to record